Nature Communications (Nov 2024)

CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner

  • Jonathan W. Lo,
  • Jan-Hendrik Schroeder,
  • Luke B. Roberts,
  • Rami Mohamed,
  • Domenico Cozzetto,
  • Gordon Beattie,
  • Omer S. Omer,
  • Ellen M. Ross,
  • Frank Heuts,
  • Geraldine M. Jowett,
  • Emily Read,
  • Matthew Madgwick,
  • Joana F. Neves,
  • Tamas Korcsmaros,
  • Richard G. Jenner,
  • Lucy S. K. Walker,
  • Nick Powell,
  • Graham M. Lord

DOI
https://doi.org/10.1038/s41467-024-51719-6
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 17

Abstract

Read online

Abstract The maintenance of intestinal homeostasis is a fundamental process critical for organismal integrity. Sitting at the interface of the gut microbiome and mucosal immunity, adaptive and innate lymphoid populations regulate the balance between commensal micro-organisms and pathogens. Checkpoint inhibitors, particularly those targeting the CTLA-4 pathway, disrupt this fine balance and can lead to inflammatory bowel disease and immune checkpoint colitis. Here, we show that CTLA-4 is expressed by innate lymphoid cells and that its expression is regulated by ILC subset-specific cytokine cues in a microbiota-dependent manner. Genetic deletion or antibody blockade of CTLA-4 in multiple in vivo models of colitis demonstrates that this pathway plays a key role in intestinal homeostasis. Lastly, we have found that this observation is conserved in human IBD. We propose that this population of CTLA-4-positive ILC may serve as an important target for the treatment of idiopathic and iatrogenic intestinal inflammation.